How does electronic cigarette smoking affect sinonasal symptoms and nasal mucociliary clearance?
OBJECTIVE
is to evaluate the sinonasal symptom scores and mucociliary clearance (MCC) after starting to use electronic cigarette METHODOLGY: This prospective randomized single-blind clinical trial was conducted between March 2013 and November 2013. Patients (n=98) admitted to smoking cessation clinic were divided into two groups; Electronic cigarette smokers (group 1) and non-electronic cigarette smokers (group 2). SNOT-22 and saccharin transit time for MCC were evaluated before starting electronic cigarettes and after the third months.


RESULTS
SNOT-22 scores and MCC time were evaluated between groups and within groups after 3 months. SNOT 22 scores and MCC measurements showed no difference between groups before the cessation of cigarette smoking (p >0.05). SNOT 22 results of both groups revealed statistically significantly lower scores after the three months (p < 0.05). However, SNOT-22 scores of group 2 was significantly better than group 1 (p > 0.05). Comparison of MCC results of group 2 revealed statistically significantly lower scores after the three months (p < 0.05). However, group 1 did not show any significant difference after three months (p > 0.05). There was a significant difference between the groups at the third month measurements (p < 0.05).


CONCLUSIONS
Although EC is widely used as a method of quitting smoking, it has negative effects on the sinonasal symptoms and MCC.
T L
TL
Kumral
Z
Z
Saltürk
G
G
Yildirim
Y
Y
Uyar
G
G
Berkiten
Y
Y
Atar
M
M
Inan
D000328:Adult; D066300:Electronic Nicotine Delivery Systems; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009079:Mucociliary Clearance; D009666:Nose; D010256:Paranasal Sinuses; D016037:Single-Blind Method; D016540:Smoking Cessation